As of Oct 1, 2025, Dimerix's P/S ratio stood at 49.28, a -81.33% change from the 263.91 P/S ratio recorded in the previous year.

The Dimerix P/S history

Dimerix Aktienanalyse

What does Dimerix do?

Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Dimerix's P/S Ratio

Dimerix's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Dimerix's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Dimerix's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Dimerix’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Dimerix stock

What is the price-to-earnings ratio of Dimerix?

The price-earnings ratio of Dimerix is currently 49.28.

How has the price-earnings ratio of Dimerix changed compared to last year?

The price-to-earnings ratio of Dimerix has increased by -81.33% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Dimerix high compared to other companies?

Yes, the price-to-earnings ratio of Dimerix is high compared to other companies.

How does an increase in the price-earnings ratio of Dimerix affect the company?

An increase in the price-earnings ratio of Dimerix would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Dimerix affect the company?

A decrease in the price-earnings ratio of Dimerix would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Dimerix?

Some factors that influence the price-earnings ratio of Dimerix are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Dimerix pay?

Over the past 12 months, Dimerix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Dimerix is expected to pay a dividend of 0 AUD.

What is the dividend yield of Dimerix?

The current dividend yield of Dimerix is .

When does Dimerix pay dividends?

Dimerix pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Dimerix?

Dimerix paid dividends every year for the past 0 years.

What is the dividend of Dimerix?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Dimerix located?

Dimerix is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dimerix kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dimerix from 10/29/1999 amounting to 0.008 AUD, you needed to have the stock in your portfolio before the ex-date on 9/24/1999.

When did Dimerix pay the last dividend?

The last dividend was paid out on 10/29/1999.

What was the dividend of Dimerix in the year 2024?

In the year 2024, Dimerix distributed 0 AUD as dividends.

In which currency does Dimerix pay out the dividend?

The dividends of Dimerix are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Dimerix

Our stock analysis for Dimerix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dimerix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.